Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Moderate and deep nurse-administered propofol sedation is safe

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Health status of refugees newly resettled in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Prevention of anastomotic leak following surgical treatment for rectal cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Diabetes mellitus affects the prognosis of frozen shoulder

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Providing targeted healthcare services for immigrants with complex health needs

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Anesthesiologists’ airway management expertise: Identifying subjective and objective knowledge gaps

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Reply to Firkins and Krishna

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Melatonin for preoperative and postoperative anxiety in adults

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

INTRODUCTION: Non-anaesthesiologist-administered propofol sedation (NAPS/NAAP) is increasingly used in many countries. Most regimens aim for light or moderate sedation. Little evidence on safety of deep NAPS sedation is available. The aim of this study was to explore the safety of intermittent deep sedation with NAPS in patients undergoing gastroenterologic endoscopic procedures.

METHODS: This was a retrospective case-control study. All patients sedated with NAPS for colonoscopies, sigmoidoscopies and oesophagogastroduodenoscopies from May 2007 through December 2012 were included. Cases were defined as patients developing an adverse event (oxygen saturation < 92%, a drop in mean arterial pressure of > 30% or a drop in systolic blood pressure of > 50 mmHg). The remaining patients served as controls.

RESULTS: A total of 6,840 consecutive patients undergoing 7,364 procedures were included. The mean propofol dose was 331.6 mg (standard deviation = 179.4 mg). The overall rate of hypoxia was 3.2%, and the rate of hypotension was 3.1%. Assisted ventilation was needed in 0.5%. Age (p < 0.001), American Society of Anesthesiologists (ASA) class 3 (p = 0.017) and total propofol dose (p = 0.001) were associated with a higher rate of adverse events.

CONCLUSION: Safety during intermittent deep sedation with NAPS was good. Age, ASA class 3 and total propofol dose were correlated with a higher rate of adverse events. Patients aged 60 years or more needed more handling during adverse events.

FUNDING: Arvid Nilsson's Foundation provided funding for this study. The founders did not have any influence on the design or the presentation of the study.

TRIAL REGISTRATION: not relevant.

OriginalsprogEngelsk
TidsskriftDanish Medical Bulletin (Online)
Vol/bind62
Udgave nummer4
Sider (fra-til)A5049
ISSN1603-9629
StatusUdgivet - apr. 2015

ID: 45680714